139 related articles for article (PubMed ID: 38151058)
21. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.
Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Vosnakis C; Katsikis I
Eur J Endocrinol; 2013 Jun; 168(6):871-7. PubMed ID: 23557988
[TBL] [Abstract][Full Text] [Related]
24. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
[TBL] [Abstract][Full Text] [Related]
25. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype.
Engmann L; Jin S; Sun F; Legro RS; Polotsky AJ; Hansen KR; Coutifaris C; Diamond MP; Eisenberg E; Zhang H; Santoro N;
Am J Obstet Gynecol; 2017 May; 216(5):493.e1-493.e13. PubMed ID: 28104402
[TBL] [Abstract][Full Text] [Related]
26. Clinical and metabolic findings in adolescent females with hyperandrogenism.
Huppert J; Chiodi M; Hillard PJ
J Pediatr Adolesc Gynecol; 2004 Apr; 17(2):103-8. PubMed ID: 15050986
[TBL] [Abstract][Full Text] [Related]
27. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
28. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
29. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
31. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
32. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial.
Al-Bayyari N; Al-Domi H; Zayed F; Hailat R; Eaton A
Clin Nutr; 2021 Mar; 40(3):870-878. PubMed ID: 33010974
[TBL] [Abstract][Full Text] [Related]
33. Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome.
Banerjee S; Raghavan S; Wasserman EJ; Linder BL; Saenger P; DiMartino-Nardi J
Pediatrics; 1998 Sep; 102(3):E36. PubMed ID: 9724684
[TBL] [Abstract][Full Text] [Related]
34. The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism.
Demirci T; Cengiz H; Varım C; Çetin S
Turk J Med Sci; 2020 Dec; 50(8):1976-1982. PubMed ID: 32892549
[TBL] [Abstract][Full Text] [Related]
35. Defining polycystic ovary syndrome phenotype in Vietnamese women.
Cao NT; Le MT; Nguyen VQH; Pilgrim J; Le VNS; Le DD; Pham CK; Aharon D; Hill MJ
J Obstet Gynaecol Res; 2019 Nov; 45(11):2209-2219. PubMed ID: 31435998
[TBL] [Abstract][Full Text] [Related]
36. Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.
Zore T; Lizneva D; Brakta S; Walker W; Suturina L; Azziz R
Fertil Steril; 2019 Feb; 111(2):389-396. PubMed ID: 30527835
[TBL] [Abstract][Full Text] [Related]
37. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.
Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz B;
Eur J Endocrinol; 2014 Oct; 171(4):489-98. PubMed ID: 25049203
[TBL] [Abstract][Full Text] [Related]
38. Comparison Of Free Androgen Index In Polycystic Ovary Syndrome And Non-Polycystic Ovary Syndrome Infertile Patients.
Khattak M; Usman R; Sultana N; Khattak A
J Ayub Med Coll Abbottabad; 2021; 33(4):577-581. PubMed ID: 35124911
[TBL] [Abstract][Full Text] [Related]
39. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
[TBL] [Abstract][Full Text] [Related]
40. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
